Insufficient scRNA-seq data for expression of ALX3 at single-cell level.
Insufficient scRNA-seq data for expression of ALX3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| uterus | 75% | 18.65 | 128 / 170 | 19% | 0.59 | 86 / 459 |
| brain | 66% | 4.69 | 1741 / 2642 | 10% | 0.25 | 71 / 705 |
| breast | 61% | 4.95 | 282 / 459 | 5% | 0.12 | 51 / 1118 |
| ovary | 47% | 1.88 | 85 / 180 | 17% | 0.64 | 72 / 430 |
| skin | 47% | 2.98 | 842 / 1809 | 4% | 0.12 | 20 / 472 |
| bladder | 38% | 1.33 | 8 / 21 | 4% | 0.14 | 21 / 504 |
| prostate | 39% | 2.55 | 96 / 245 | 0% | 0 | 0 / 502 |
| tonsil | 0% | 0 | 0 / 0 | 31% | 0.69 | 14 / 45 |
| esophagus | 12% | 0.32 | 168 / 1445 | 9% | 0.38 | 17 / 183 |
| lung | 9% | 0.29 | 53 / 578 | 9% | 0.21 | 100 / 1155 |
| thymus | 15% | 0.49 | 96 / 653 | 1% | 0.02 | 7 / 605 |
| adipose | 11% | 0.35 | 133 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 10% | 0.37 | 133 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 3% | 0.07 | 12 / 359 | 5% | 0.09 | 13 / 286 |
| liver | 1% | 0.03 | 3 / 226 | 6% | 0.11 | 23 / 406 |
| heart | 6% | 0.14 | 49 / 861 | 0% | 0 | 0 / 0 |
| spleen | 5% | 0.13 | 13 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 5% | 0.10 | 15 / 328 | 1% | 0.01 | 1 / 178 |
| adrenal gland | 5% | 0.67 | 12 / 258 | 0% | 0.01 | 1 / 230 |
| intestine | 4% | 0.08 | 35 / 966 | 1% | 0.02 | 5 / 527 |
| muscle | 4% | 0.10 | 34 / 803 | 0% | 0 | 0 / 0 |
| kidney | 3% | 0.08 | 3 / 89 | 1% | 0.01 | 6 / 901 |
| peripheral blood | 4% | 0.15 | 34 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048704 | Biological process | embryonic skeletal system morphogenesis |
| GO_0035115 | Biological process | embryonic forelimb morphogenesis |
| GO_0042981 | Biological process | regulation of apoptotic process |
| GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
| GO_0007389 | Biological process | pattern specification process |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| Gene name | ALX3 |
| Protein name | ALX homeobox 3 Homeobox protein aristaless-like 3 (Proline-rich transcription factor ALX3) |
| Synonyms | |
| Description | FUNCTION: Transcriptional regulator with a possible role in patterning of mesoderm during development. . |
| Accessions | A0A3B3IS30 O95076 ENST00000647563.2 ENST00000649954.1 |